Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: GlobalData
Provider: Stock Traders Daily
Provider: New Constructs, LLC

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Myriad Genetics Inc raises FY 2014 guidance

Tuesday, 4 Feb 2014 04:05pm EST 

Myriad Genetics Inc:Raised FY 2014 guidance.Expects FY 2014 revenue to be in the range of $740-$750 mln, compared to previous guidance of $700 to $715 mln.Expects diluted EPS of $2.09-$2.12 compared to previous guidance of $1.92-$1.97.FY 2014 revenue of $705 mln and EPS of $1.97 - Thomson Reuters I/B/E/S. 

Company Quote

19 Dec 2014